Home » Topics » Regulatory » EMA

EMA
RSS

EMA grants SME designation to Dipexium Pharmaceuticals

Oct. 5, 2016

EMA accepts for review MAA for Herceptin biosimilar SB-3

Oct. 4, 2016

EMA accepts and validates masitinib MAA for ALS

Oct. 3, 2016

FDA grants orphan drug designation to BIIB-067 for the treatment of ALS

Sep. 26, 2016

EMA premature in notification of SomaKit TOC opinion

Sep. 23, 2016

EMA grants PRIME scheme access to Bluebird's Lentiglobin and Juno's JCAR-015

Sep. 22, 2016

AstraZeneca withdraws MAA for cediranib

Sep. 22, 2016

EMA validates BMS' application to extend Opdivo indications

Sep. 21, 2016

EMA issues positive opinion on the MAA for SomaKit TOC

Sep. 20, 2016

Pfizer receives positive CHMP opinion for Ibrance in Europe

Sep. 19, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...